ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 40518115

FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems.

Wang J and 10 others. J Adv Res, 2025. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems. Papers, record 40518115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40518115

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems.
PubMed
Journal
J Adv Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.77, provisional
iCite
Revised in PubMed
2026-09-04
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang JJuan
2Xing LLijuan
3Song YYang
4Yang YYue
5Zhang YYinzhuo
6Ma HHaoxiang
7Su BBenyu
8Su LLuoxuan
9Ma CChao
10Liu MMingyan

1 to 10 of 11Source PubMed

See all 11 authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Fibroblast Growth FactorsMajor topic
Drug Delivery SystemsMajor topic
Neuroinflammatory DiseasesMajor topic
Receptors, Fibroblast Growth FactorMajor topic
Humans
Signal Transduction
Animals
Alzheimer Disease

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References189

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116,597,617Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.J Biol Chem2006https://conductscience.org/library/papers/16597617PubMed
229,451,369Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor.ChemMedChem2018https://conductscience.org/library/papers/29451369PubMed
330,410,033Multiple sclerosis.Nat Rev Dis Primers2018https://conductscience.org/library/papers/30410033PubMed
433,753,146Paeoniflorin exerts antidepressant-like effects through enhancing neuronal FGF-2 by microglial inactivation.J Ethnopharmacol2021https://conductscience.org/library/papers/33753146PubMed
536,216,899Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1.Acta Pharmacol Sin2023https://conductscience.org/library/papers/36216899PubMed
625,150,008"Mesenchymal" stem cells.Annu Rev Cell Dev Biol2014https://conductscience.org/library/papers/25150008PubMed
739,043,538Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands.Cytokine Growth Factor Rev2024https://conductscience.org/library/papers/39043538PubMed
830,300,457Multiple sclerosis - a review.Eur J Neurol2019https://conductscience.org/library/papers/30300457PubMed
938,076,728Modified FGF Hydrogel for Effective Axon Formation by Enhanced Regeneration of Myelin Sheath of Schwann Cells Using Rat Model.Int J Nanomedicine2023https://conductscience.org/library/papers/38076728PubMed
1016,388,853Immune and inflammatory mechanisms in neuropathic pain.Brain Res Rev2006https://conductscience.org/library/papers/16388853PubMed

1 to 10 of 189

See all 189 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42,633,326Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.MedComm (2020)2026https://conductscience.org/library/papers/42633326PubMed
42,315,909Fibroblast growth factors in ischemic stroke: Therapeutic potential and clinical challenges.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42315909PubMed
41,838,132PLGA nanoparticles encapsulating fibroblast growth factor 21 alleviate acetaminophen-induced acute liver injury.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41838132PubMed
41,724,112Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study.EBioMedicine2026https://conductscience.org/library/papers/41724112PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40518115

GET https://conductscience.org/api/papers/v1/40518115/references?page=2

API referenceFor AI assistants